JANUS HENDERSON INVESTORS US LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 30 filers reported holding PROQR THRAPEUTICS N V in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON INVESTORS US LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2017$1,919,000
-0.6%
383,821
-2.5%
0.00%0.0%
Q4 2016$1,930,000
-28.0%
393,860
-2.0%
0.00%0.0%
Q3 2016$2,682,000
+34.5%
402,096
-2.4%
0.00%0.0%
Q2 2016$1,994,000
-4.5%
411,983
-3.8%
0.00%0.0%
Q1 2016$2,089,000
-68.7%
428,161
-44.3%
0.00%
-66.7%
Q4 2015$6,678,000
-70.3%
769,337
-50.2%
0.01%
-40.0%
Q3 2015$22,490,000
+47.3%
1,543,624
+68.6%
0.01%
-23.1%
Q2 2015$15,263,000
-37.4%
915,576
-17.8%
0.01%
-35.0%
Q1 2015$24,365,000
+50.6%
1,113,568
+49.2%
0.02%
+42.9%
Q4 2014$16,177,000
+34.7%
746,525
+6.8%
0.01%
+27.3%
Q3 2014$12,013,000698,8380.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2014
NameSharesValueWeighting ↓
Redmile Group, LLC 1,602,975$7,774,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 530,000$2,571,0000.37%
Nine Chapters Capital Management LLC 27,400$133,0000.29%
Artal Group S.A. 1,500,000$7,275,0000.12%
Orbimed Advisors 2,295,346$11,132,0000.11%
ALTRINSIC GLOBAL ADVISORS LLC 191,360$928,0000.04%
THOMPSON DAVIS & CO., INC. 2,000$10,0000.02%
JENNISON ASSOCIATES LLC 2,457,360$11,918,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 14,700$71,0000.01%
Virtu Financial LLC 13,150$64,0000.00%
View complete list of PROQR THRAPEUTICS N V shareholders